Induction of BRAF V600E alone was not tumorigenic; Ink4a/Arf loss in combination produced well-demarcated gliomas showing evidence of growth into the subarachnoid space, recapitulating the characteristics of epithelioid GBM. The gene discussed is CDKN2A; the disease is glioblastoma.